Skip to Main Content

Try STAT+ TODAY

Pharma

Taking stock of the drug industry, from the lab to the medicine chest. For a weekly update, sign up for our free Pharmalot newsletter. And subscribe to STAT+ for exclusive coverage and analysis of the pharma industry — from drug pipelines to boardroom shakeups.

gavel pill patent

Pharmalot By Ed Silverman

Drugmakers win court battle over an HHS rule that would have penalized them for offering copay coupons

The pharmaceutical industry argued the rule would have made it harder to offer assistance programs to commercially insured patients.

Martin Shkreli

Pharmalot By Ed Silverman

‘Pharma bro’ Martin Shkreli released from prison

Pharmalot By Ed Silverman

Pharmalittle: Moderna chair defends executive hiring process; analysis finds monopoly tactics preserve inhaler revenues

Blue inhaler

Pharmalot By Ed Silverman

Drugmakers use monopoly tactics to thwart lower-cost generic competition for inhalers, analysis finds

Health Risk Calculators

Pharmalot By Ed Silverman

High blood pressure pills are costly — but also hard to find — in some lower-income countries

All Coverage

Diversity in clinical trials concept

Health By Usha Lee McFarling

National Academies report cites ‘urgent’ need to recruit more diverse participants for clinical trials

Pharmalot By Ed Silverman

Pharmalittle: FDA declines to approve old antidepressant for Covid; U.S.-China trade fight may derail WTO Covid patent waiver

advertisement

Pills dollar QALY

Pharmalot By Ed Silverman

Two dozen states side with HHS in its raucous dispute with pharma over a drug discount program

Bribery

Pharmalot By Ed Silverman

Greece plans to go to court to seek compensation from Novartis over a bribery scandal

Pharmalot By Ed Silverman

Pharmalittle: FDA OKs new type of diabetes drug from Lilly; Early-stage biotechs are juicy targets for M&A surge

Pharmalot Coming/Going STILL

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: Aspen may close South Africa Covid vaccine plant due to lack of orders; Roche insists it can overcome latest setback

Kolassa drug pricing

First Opinion By Billy Kenber

The man behind ‘value-based pricing’ saw pharma distorting his message — and walked away

Worldwide Covid-19 vaccinations

Pharmalot By Ed Silverman

National Institutes of Health licenses nearly a dozen Covid-19 technologies to a WHO program

pile of insulin syringes

Pharmalot By Ed Silverman

Arkansas becomes the latest state to sue drugmakers and PBMs over insulin pricing

Pharmalot By Ed Silverman

Pharmalittle: Seagen chief executive is arrested for domestic assault; abortion pill producer has ample supplies

Sen. Bill Cassidy (R-LA)

Pharmalot By Ed Silverman

Lawmakers wade into a contentious battle over orphan drug monopolies

Pharmalot By Ed Silverman

Pharmalittle: Moderna’s new CFO leaves due to probe by former employer; Roche suffers another setback with a cancer drug

Roche HQ

Biotech By Adam Feuerstein

Roche anti-TIGIT cancer immunotherapy fails second clinical trial, raising doubts about drug class

Covid vaccines

Pharmalot By Ed Silverman

Why a controversial patent rights waiver could be a ‘missed opportunity’ to tackle the next pandemic

Pharmalot By Ed Silverman

Pharmalittle: Pfizer to pay $11.6 billion for Biohaven; pharmacy chains face a novel trial to determine opioid liability

Pharmalot By Damian Garde

Pharmalittle: Seagen CEO under investigation after alleged domestic violence; Bausch & Lomb settles for a lesser IPO

Pharmalot Coming/Going STILL

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: FDA restricts access to J&J Covid-19 vaccine; Novartis halts production of two cancer drugs over quality issues

Pharmalot By Ed Silverman

Novartis suspends production of two cancer therapies over potential quality issues

Balance innovation

First Opinion By Anand Kumar

Exploitation in the name of biomedical innovation cannot be tolerated

Pharmalot By Ed Silverman

Pharmalittle: Abortion pill demand may rise if Roe v Wade is overturned; U.S. lawmakers move toward revamping accelerated approval

Drug pricing transparency

Pharmalot By Ed Silverman

J&J sues a behind-the-scenes company for exploiting its patient assistance program

International Clinical Trials

Pharmalot By Ed Silverman

Race is often overlooked in key clinical trial data used to win new drug approvals in Europe